Programmed Death-Ligand 1 (PD-L1) is a protein that plays a crucial role in suppressing the adaptive arm of the immune system. PD-L1 binds to the PD-1 receptor found on T-cells, leading to the inhibition of T-cell activity and allowing cancer cells to evade the immune response. This interaction is a significant target in cancer immunotherapy.
